Genetic Sequence Changes Related to the Attenuation of Avian Infectious Bronchitis Virus Strain TW2575/98

Overview

Journal Virus Genes

Specialties Microbiology
Molecular Biology

Date 2020 Apr 2

PMID 32232712

Citations 5

Authors

Cheng-Ta Tsai

Hung-Yi Wu

Ching-Ho Wang

Affiliations

Soon will be listed here.

Abstract

The attenuated avian infectious bronchitis virus (IBV), derived from a wild strain (TW2575/98w) in chicken embryos after 75 passages, is designed as a commercial vaccine strain (TW2575/98vac) to control the disease in Taiwan. The differences in viral infectivity, replication efficiency, and genome sequences between TW2575/98w and TW2575/98vac were determined and compared. TW2575/98vac caused earlier death of chicken embryos and had higher viral replication efficiency. Thirty amino acid substitutions resulting from 44 mutated nucleotides in the viral genome were found in TW2575/98vac. All of the molecular variations lead to attenuation, found in TW2575/98, were not observed consistently in the other IBVs (TW2296/95, Ark/Ark-DPI/81, the Massachusetts strain, GA98/CWL0470/98, and CK/CH/LDL/97I) and vice versa. After further comparisons and evaluations from three aspects: (1) longitudinal analysis on the timing of variations appeared in specific homologous strain passages, (2) horizontal evaluations with the amino acid changes between wild and vaccine strains among the other 5 IBVs, and (3) inspection on alterations in the chemical characteristics of substituted amino acid residues in viral proteins, four amino acid substitutions [V342D in p87, S1493P and P2025S in HD1, as well as F2308Y in HD1(P41)] were selected as highly possible candidates for successful TW2575/98w attenuation. Our findings imply that molecular variations, which contribute to the successful attenuation of different IBVs, are diverse and not restricted to a fixed pattern or specific amino acid substitutions in viral proteins. In addition, four amino acid changes within the replicase gene-encoded proteins might be associated with TW2575/98 virus virulence.

Citing Articles

Potential Transcriptional Enhancers in Coronaviruses: From Infectious Bronchitis Virus to SARS-CoV-2.

Patarca R, Haseltine W Int J Mol Sci. 2024; 25(15).

PMID: 39125583 PMC: 11311688. DOI: 10.3390/ijms25158012.

An Amplicon-Based Application for the Whole-Genome Sequencing of GI-19 Lineage Infectious Bronchitis Virus Directly from Clinical Samples.

Le H, Thai T, Kim J, Song H, Her M, Tran X Viruses. 2024; 16(4).

PMID: 38675858 PMC: 11054852. DOI: 10.3390/v16040515.

Reverse Genetics and Its Usage in the Development of Vaccine Against Poultry Diseases.

Nath B, Morla S, Kumar S Methods Mol Biol. 2021; 2411:77-92.

PMID: 34816399 DOI: 10.1007/978-1-0716-1888-2_4.

Metagenomic sequencing determines complete infectious bronchitis virus (avian Gammacoronavirus) vaccine strain genomes and associated viromes in chicken clinical samples.

Van Borm S, Steensels M, Mathijs E, Vandenbussche F, van den Berg T, Lambrecht B Virus Genes. 2021; 57(6):529-540.

PMID: 34626348 PMC: 8501334. DOI: 10.1007/s11262-021-01872-7.

Infectious Bronchitis Virus in Egypt: Genetic Diversity and Vaccination Strategies.

Abozeid H, Naguib M Vet Sci. 2020; 7(4).

PMID: 33348570 PMC: 7766096. DOI: 10.3390/vetsci7040204.

References

Pickett B, Sadat E, Zhang Y, Noronha J, Squires R, Hunt V . ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2011; 40(Database issue):D593-8. PMC: 3245011. DOI: 10.1093/nar/gkr859. View

Zhao Y, Cheng J, Yan S, Jia W, Zhang K, Zhang G . S gene and 5a accessory gene are responsible for the attenuation of virulent infectious bronchitis coronavirus. Virology. 2019; 533:12-20. PMC: 7112010. DOI: 10.1016/j.virol.2019.04.014. View

Andrade J, Estevez-Perez M . Statistical comparison of the slopes of two regression lines: A tutorial. Anal Chim Acta. 2014; 838:1-12. DOI: 10.1016/j.aca.2014.04.057. View

Huang Y, Wang C . Development of attenuated vaccines from Taiwanese infectious bronchitis virus strains. Vaccine. 2005; 24(6):785-91. PMC: 7115542. DOI: 10.1016/j.vaccine.2005.08.081. View

Spaan W, Cavanagh D, Horzinek M . Coronaviruses: structure and genome expression. J Gen Virol. 1988; 69 ( Pt 12):2939-52. DOI: 10.1099/0022-1317-69-12-2939. View

Ammayappan A, Upadhyay C, Gelb Jr J, Vakharia V . Identification of sequence changes responsible for the attenuation of avian infectious bronchitis virus strain Arkansas DPI. Arch Virol. 2009; 154(3):495-9. PMC: 7086983. DOI: 10.1007/s00705-009-0325-9. View

Brierley I, Digard P, Inglis S . Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot. Cell. 1989; 57(4):537-47. PMC: 7133225. DOI: 10.1016/0092-8674(89)90124-4. View

Huo Y, Huang Q, Lu M, Wu J, Lin S, Zhu F . Attenuation mechanism of virulent infectious bronchitis virus strain with QX genotype by continuous passage in chicken embryos. Vaccine. 2015; 34(1):83-9. DOI: 10.1016/j.vaccine.2015.11.008. View

Cavanagh D, Casais R, Armesto M, Hodgson T, Izadkhasti S, Davies M . Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins. Vaccine. 2007; 25(30):5558-62. PMC: 7115386. DOI: 10.1016/j.vaccine.2007.02.046. View

10.

Wang C, Tsai C . Genetic grouping for the isolates of avian infectious bronchitis virus in Taiwan. Arch Virol. 1996; 141(9):1677-88. PMC: 7086916. DOI: 10.1007/BF01718291. View

11.

Liu S, Zhang X, Gong L, Yan B, Li C, Han Z . Altered pathogenicity, immunogenicity, tissue tropism and 3'-7kb region sequence of an avian infectious bronchitis coronavirus strain after serial passage in embryos. Vaccine. 2009; 27(34):4630-40. PMC: 7115700. DOI: 10.1016/j.vaccine.2009.05.072. View

12.

Mardani K, Browning G, Ignjatovic J, Noormohammadi A . Rapid differentiation of current infectious bronchitis virus vaccine strains and field isolates in Australia. Aust Vet J. 2006; 84(1-2):59-62. DOI: 10.1111/j.1751-0813.2006.tb13130.x. View

13.

Shien J, Su Y, Wu H . Regulation of coronaviral poly(A) tail length during infection is not coronavirus species- or host cell-specific. Virus Genes. 2014; 49(3):383-92. PMC: 7089208. DOI: 10.1007/s11262-014-1103-7. View

14.

Keep S, Bickerton E, Armesto M, Britton P . The ADRP domain from a virulent strain of infectious bronchitis virus is not sufficient to confer a pathogenic phenotype to the attenuated Beaudette strain. J Gen Virol. 2018; 99(8):1097-1102. PMC: 6171709. DOI: 10.1099/jgv.0.001098. View

15.

Bijlenga G, Cook J, Gelb Jr J, de Wit J . Development and use of the H strain of avian infectious bronchitis virus from the Netherlands as a vaccine: a review. Avian Pathol. 2005; 33(6):550-7. PMC: 7154294. DOI: 10.1080/03079450400013154. View

16.

Huang Y, Wang C . Sequence changes of infectious bronchitis virus isolates in the 3' 7.3 kb of the genome after attenuating passage in embryonated eggs. Avian Pathol. 2007; 36(1):59-67. DOI: 10.1080/03079450601110015. View

17.

Shan D, Fang S, Han Z, Ai H, Zhao W, Chen Y . Effects of hypervariable regions in spike protein on pathogenicity, tropism, and serotypes of infectious bronchitis virus. Virus Res. 2018; 250:104-113. PMC: 7114591. DOI: 10.1016/j.virusres.2018.04.013. View

18.

Feng K, Xue Y, Wang J, Chen W, Chen F, Bi Y . Development and efficacy of a novel live-attenuated QX-like nephropathogenic infectious bronchitis virus vaccine in China. Vaccine. 2015; 33(9):1113-20. PMC: 7127481. DOI: 10.1016/j.vaccine.2015.01.036. View

19.

Hodgson T, Casais R, Dove B, Britton P, Cavanagh D . Recombinant infectious bronchitis coronavirus Beaudette with the spike protein gene of the pathogenic M41 strain remains attenuated but induces protective immunity. J Virol. 2004; 78(24):13804-11. PMC: 533908. DOI: 10.1128/JVI.78.24.13804-13811.2004. View

20.

Casais R, Davies M, Cavanagh D, Britton P . Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication. J Virol. 2005; 79(13):8065-78. PMC: 1143771. DOI: 10.1128/JVI.79.13.8065-8078.2005. View